DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, plans to reports on its financial results for the first quarter ended March 31, 2023; the company will release the report on May 11, 2023, before market open. In addition, DarioHealth has scheduled an earnings conference call and webcast to discuss the report. The event will be held on the same day at 8:30 a.m. ET. DarioHealth CEO Erez Raphael, president Rick Anderson and CFO Zvi Ben-David will host the call and webcast. Those interested can participate by dialing 1-833-816-1389 (domestic) or 1-412-317-0482 (international), then using the passcode 9873766. Participants can also use a Call me(TM) link for instant access to the call. In addition, a replay of the call will be available through June 11, 2023. Those interested in accessing the replay can dial 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and use replay passcode 10178111.
To view the event, visit https://ibn.fm/KGVTY
To view the full press release, visit https://ibn.fm/14tEf
About DarioHealth Corp.
DarioHealth Corp. is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition digital therapeutics platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. The company’s user-centric platform offers users continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results, and making the right thing to do the easy thing to do. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers and providers of care as well as directly to consumers. For more information about the company, please visit www.DarioHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork
